These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 33137172)
1. Prevalence of Latent Tuberculosis Infection Among Non-US-Born Persons by Country of Birth-United States, 2012-2017. Collins JM; Stout JE; Ayers T; Hill AN; Katz DJ; Ho CS; Blumberg HM; Winglee K; Clin Infect Dis; 2021 Nov; 73(9):e3468-e3475. PubMed ID: 33137172 [TBL] [Abstract][Full Text] [Related]
2. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity. Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612 [TBL] [Abstract][Full Text] [Related]
3. Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey. Yelk Woodruff R; Hill A; Marks S; Navin T; Miramontes R J Immigr Minor Health; 2021 Aug; 23(4):806-812. PubMed ID: 32761297 [TBL] [Abstract][Full Text] [Related]
4. Evaluating latent tuberculosis infection diagnostics using latent class analysis. Stout JE; Wu Y; Ho CS; Pettit AC; Feng PJ; Katz DJ; Ghosh S; Venkatappa T; Luo R; Thorax; 2018 Nov; 73(11):1062-1070. PubMed ID: 29982223 [TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States. Annan E; Stockbridge EL; Katz D; Mun EY; Miller TL Medicine (Baltimore); 2021 Feb; 100(7):e24838. PubMed ID: 33607853 [TBL] [Abstract][Full Text] [Related]
6. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test? Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445 [TBL] [Abstract][Full Text] [Related]
7. Latent tuberculosis infection prevalence in second generation immigrants from high to low TB burden countries. Shlomi D; Galor I; More A; Oberman B; Fireman L Pulmonology; 2023; 29(2):124-129. PubMed ID: 33408042 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States. Holzman SB; Perry A; Saleeb P; Pyan A; Keh C; Salcedo K; Narita M; Ahmed A; Miller TL; Pettit AC; Khurana R; Whipple M; Katz D; Largen A; Krueger A; Shah M; Clin Infect Dis; 2022 Nov; 75(10):1792-1799. PubMed ID: 35363249 [TBL] [Abstract][Full Text] [Related]
9. Duration of Exposure Among Close Contacts of Patients With Infectious Tuberculosis and Risk of Latent Tuberculosis Infection. Reichler MR; Khan A; Yuan Y; Chen B; McAuley J; Mangura B; Sterling TR; Clin Infect Dis; 2020 Oct; 71(7):1627-1634. PubMed ID: 32044987 [TBL] [Abstract][Full Text] [Related]
10. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Shea KM; Kammerer JS; Winston CA; Navin TR; Horsburgh CR Am J Epidemiol; 2014 Jan; 179(2):216-25. PubMed ID: 24142915 [TBL] [Abstract][Full Text] [Related]
11. Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test. Legesse M; Ameni G; Mamo G; Medhin G; Bjune G; Abebe F BMC Infect Dis; 2011 Apr; 11():89. PubMed ID: 21477326 [TBL] [Abstract][Full Text] [Related]
12. Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022. Woodruff R; Pratt R; Kolasa M MMWR Surveill Summ; 2024 Jun; 73(4):1-18. PubMed ID: 38833409 [TBL] [Abstract][Full Text] [Related]
13. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. Shah M; DiPietro D; Greenbaum A; Ketemepi S; Martins-Evora M; Marsiglia V; Dorman SE PLoS One; 2012; 7(5):e36551. PubMed ID: 22586476 [TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis. Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688 [TBL] [Abstract][Full Text] [Related]
15. Assessing the Prevalence of Latent Tuberculosis among Health Care Providers in Zagazig City, Egypt Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test. El-Sokkary RH; Abu-Taleb AM; El-Seifi OS; Zidan HE; Mortada EM; El-Hossary D; Farag SE Cent Eur J Public Health; 2015 Dec; 23(4):324-30. PubMed ID: 26841146 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country. Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Diagnosis of Latent Tuberculosis Infection in Young Children in the Absence of a Gold Standard. Perez-Porcuna TM; Pereira-da-Silva HD; Ascaso C; Malheiro A; Bührer S; Martinez-Espinosa F; Abellana R PLoS One; 2016; 11(10):e0164181. PubMed ID: 27783642 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for latent tuberculosis infection in children in South Korea. Son M; Park YS; Jung MH; Kang JH; Choi UY Postgrad Med; 2018 Sep; 130(7):637-643. PubMed ID: 30095331 [TBL] [Abstract][Full Text] [Related]
19. Risk of progression to active tuberculosis among foreign-born persons with latent tuberculosis. Patel S; Parsyan AE; Gunn J; Barry MA; Reed C; Sharnprapai S; Horsburgh CR Chest; 2007 Jun; 131(6):1811-6. PubMed ID: 17413054 [TBL] [Abstract][Full Text] [Related]
20. Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors. Almohaya A; Aldrees A; Akkielah L; Hashim AT; Almajid F; Binmoammar T; Barry MA Ann Saudi Med; 2020; 40(3):191-199. PubMed ID: 32493098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]